Nitric oxide and superoxide inhibit platelet-derived growth factor receptor phosphotyrosine phosphatases

Free Radical Biology and Medicine

Volumn 26, Issue 11-12, 1999, Pages 1544-1553

  Callsen, Dagmar ^a   Sandau, Katrin B ^a   Brüne, Bernhard ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Free radicals; Nitric oxide; Oxidation; PDGF receptor; S nitrosylation; Tyrosine phosphatase inhibition; Tyrosine phosphorylation

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 4 NITROPHENYL PHOSPHATE; ACETYLCYSTEINE; CYCLIC AMP; CYCLIC GMP DERIVATIVE; FREE RADICAL; INTERLEUKIN 1BETA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORTHOVANADIC ACID; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE; SUPEROXIDE; TYRPHOSTIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; MESANGIUM CELL; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; ENZYME INDUCTION; ENZYME INHIBITORS; GLOMERULAR MESANGIUM; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SUPEROXIDES; UP-REGULATION;

ANIMALIA;

EID: 0033046078     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00015-5     Document Type: Article

References (49)

1. Pfeilschifter J., Hosang M. Effects of homo- and heterodimeric isoforms of PDGF on signalling events in rat renal mesangial cells. Cell Signal. 3:1991;413-424.
2. Meyer Ingold W., Eichner W. Platelet-derived growth factor. Cell Biol. Int. 19:1995;389-398.
3. Johnson R., Iida H., Yoshimura A., Floege J., Bowen Pope D.F. Platelet-derived growth factor a potentially important cytokine in glomerular disease . Kidney Int. 41:1992;590-594.
4. Abboud H.E. Growth factors and the mesangium. J. Am. Soc. Nephrol. 2:1992;S185-S189.
5. Heldin C.H., Backstrom G., Ostman A., Hammacher A., Ronnstrand L., Rubin K., Nister M., Westermark B. Binding of different dimeric forms of PDGF to human fibroblasts evidence for two separate receptor types . EMBO J. 7:1988;1387-1393.
6. Lemmon M.A., Schlessinger J. Regulation of signal transduction and signal diversity by receptor oligomerization. Trends. Biochem. Sci. 19:1994;459-463.
7. Claesson Welsh L. Signal transduction by the PDGF receptors. Prog. Growth Factor. Res. 5:1994;37-54.
8. Sun H., Tonks N.K. The coordinated action of protein tyrosine phosphatases and kinases in cell signaling. Trends. Biochem. Sci. 19:1994;480-485.
9. Hunter T. Protein kinases and phosphatases the yin and yang of protein phosphorylation and signaling . Cell. 80:1995;225-236.
10. Fauman E.B., Saper M.A. Structure and function of the protein tyrosine phosphatases. Trends. Biochem. Sci. 21:1996;413-417.
11. Denu J.M., Stuckey J.A., Saper M.A., Dixon J.E. Form and function in protein dephosphorylation. Cell. 87:1996;361-364. [comment].
12. Stone R.L., Dixon J.E. Protein-tyrosine phosphatases. J. Biol. Chem. 269:1994;31323-31326.
13. Guan K.L., Dixon J.E. Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J. Biol. Chem. 266:1991;17026-17030.
14. Nathan C., Xie Q.W. Nitric oxide synthases roles, tolls, and controls . Cell. 78:1994;915-918.
15. Marletta M.A. Nitric oxide synthase aspects concerning structure and catalysis . Cell. 78:1994;927-930.
16. Narita I., Border W.A., Ketteler M., Noble N.A. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis [see comments]. Lab. Invest. 72:1995;17-24.
17. Feelisch, M.; Stamler, J. S. eds. Donors of nitrogen oxides, Methods in nitric oxide research. 71-115, New York: John Wiley & Sons; 1996.
18. Stamler J.S. Redox signaling nitrosylation and related target interactions of nitric oxide . Cell. 78:1994;931-936.
19. Stamler J.S., Singel D.J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 258:1992;1898-1902. [see comments].
20. Schmidt H.H., Walter U. NO at work. Cell. 78:1994;919-925.
21. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
22. Mohr S., Stamler J.S., Brüne B. Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment. J. Biol. Chem. 271:1996;4209-4214.
23. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso- compounds [see comments]. Nature. 364:1993;626-632.
24. Lander H.M., Hajjar D.P., Hempstead B.L., Mirza U.A., Chait B.T., Campbell S., Quilliam L.A. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J. Biol. Chem. 272:1997;4323-4326.
25. Rosen G.M., Pou S., Ramos C.L., Cohen M.S., Britigan B.E. Free radicals and phagocytic cells. FASEB J. 9:1995;200-209.
26. Radeke H.H., Meier B., Topley N., Floge J., Habermehl G.G., Resch K. Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int. 37:1990;767-775.
27. Pfeilschifter J., Vosbeck K. Transforming growth factor beta 2 inhibits interleukin 1 beta- and tumour necrosis factor alpha-induction of nitric oxide synthase in rat renal mesangial cells. Biochem. Biophys. Res. Commun. 175:1991;372-379.
28. Hart T.W. Some observations concerning the S-nitroso and S-phenylsulphonyl derivates of L-cysteine and glutathione. Tetrahedron Lett. 26:1985;2013-2016.
29. Messmer U.K., Lapetina E.G., Brüne B. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol. Pharmacol. 47:1995;757-765.
30. Knebel A., Rahmsdorf H.J., Ullrich A., Herrlich P. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 15:1996;5314-5325.
31. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione applications to mammalian blood and other tissues . Anal. Biochem. 27:1969;502-522.
32. Sandau K., Pfeilschifter J., Brüne B. The balance between nitric oxide and superoxide determines apoptotic and necrotic death of rat mesangial cells. J. Immunol. 158:1997;4938-4946.
33. Leuthauser S.W., Oberley L.W., Oberley T.D., Sorenson J.R., Ramakrishna K. Antitumor effect of a copper coordination compound with superoxide dismutase-like activity. J. Natl. Cancer Inst. 66:1981;1077-1081.
34. Woods J.S., Ellis M.E. Up-regulation of glutathione synthesis in rat kidney by methyl mercury. Relationship to mercury-induced oxidative stress. Biochem. Pharmacol. 50:1995;1719-1724.
35. Orrenius S., Moldeus P. The multiple roles of glutathione in drug metabolism. Trends. Biochem. Sci. 9:1984;432-435.
36. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
37. Barford D. Protein phosphatases. Curr. Opin. Struct. Biol. 5:1995;728-734.
38. Stamler J.S., Toone E.J., Lipton S.A., Sucher N.J. (S)NO signals translocation, regulation, and a consensus motif . Neuron. 18:1997;691-696.
39. Huyer G., Liu S., Kelly J., Moffat J., Payette P., Kennedy B., Tsaprailis G., Gresser M.J., Ramachandran C. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J. Biol. Chem. 272:1997;843-851.
40. Cavigelli M., Li W.W., Lin A., Su B., Yoshioka K., Karin M. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J. 15:1996;6269-6279.
41. Wenzel U.O., Fouqueray B., Biswas P., Grandaliano G., Choudhury G.G., Abboud H.E. Activation of Mesangial Cells by the Phosphatase Inhibitor Vanadate. J. Clin. Invest. 95:1995;1244-1252.
42. Lander H.M., Sehajpal P., Levine D.M., Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1993;1509-1516.
43. Peranovich T.M., da Silva A.M., Fries D.M., Stern A., Monteiro H.P. Nitric oxide stimulates tyrosine phosphorylation in murine fibroblasts in the absence and presence of epidermal growth factor. Biochem. J. 305:1995;613-619.
44. Caselli A., Camici G., Manao G., Moneti G., Pazzagli L., Cappugi G., Ramponi G. Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase. J. Biol. Chem. 269:1994;24878-24882.
45. Lo Y.Y.C., Wong J.M.S., Cruz T.F. Reactive oxygen species mediate cytokine activation of c-Jun NH2- terminal kinases. J. Biol. Chem. 271:1996;15703-15707.
46. Imbert V., Rupec R.A., Livolsi A., Pahl H.L., Traenckner E.B., Mueller Dieckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P.A., Peyron J.F. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell. 86:1996;787-798.
47. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 9:1995;726-735.
48. Guan K.L. The mitogen activated protein kinase signal transduction pathway from the cell surface to the nucleus . Cell Signal. 6:1994;581-589.
49. Lander H.M., Jacovina A.T., Davis R.J., Tauras J.M. Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J. Biol. Chem. 271:1996;19705-19709.